4//SEC Filing
Pacira Pharmaceuticals, Inc. 4
Accession 0001181431-13-034558
$PCRXCIK 0001396814operating
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 7:30 PM ET
Size
12.9 KB
Accession
0001181431-13-034558
Insider Transaction Report
Form 4
Pratt John
General Manager, San Diego
Transactions
- Sale
Common Stock
2013-06-10$30.00/sh−5,398$161,940→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-06-11−12,945→ 131,657 totalExercise: $10.81Exp: 2022-06-04→ Common Stock (12,945 underlying) - Exercise/Conversion
Common Stock
2013-06-10$10.81/sh+5,398$58,352→ 5,398 total - Exercise/Conversion
Common Stock
2013-06-11$10.81/sh+12,945$139,935→ 12,945 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-06-10−5,398→ 144,602 totalExercise: $10.81Exp: 2022-06-04→ Common Stock (5,398 underlying) - Sale
Common Stock
2013-06-11$30.00/sh−12,945$388,350→ 0 total
Footnotes (1)
- [F1]The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vests and becomes exercisable as to the remaining shares in successive equal monthly installments for the subsequent 36 months.
Documents
Issuer
Pacira Pharmaceuticals, Inc.
CIK 0001396814
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001396814
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 7:30 PM ET
- Size
- 12.9 KB